norgestimate has been researched along with levonorgestrel in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.56) | 18.7374 |
| 1990's | 17 (47.22) | 18.2507 |
| 2000's | 13 (36.11) | 29.6817 |
| 2010's | 3 (8.33) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Dain, MP; Janaud, A; Rouffy, J; Upmalis, D | 1 |
| Chapdelaine, A; London, RS; Olson, W; Smith, J; Upmalis, D | 1 |
| Hahn, DW; McGuire, JL; Phillips, A | 1 |
| Flor, S; Hahn, DW; Kafrissen, ME; McGuire, JL; Phillips, A; Tolman, EL | 1 |
| Roy, S; Stanczyk, FZ | 1 |
| Rabe, T; Runnebaum, B | 1 |
| Hahn, DW; Hetyei, NS; Killinger, J; McGuire, JL; Phillips, A | 1 |
| Donnez, J; Grandjean, P; Lavenne, E; Schlit, AF | 1 |
| Fritzemeier, KH; Hegele-Hartung, C; Krattenmacher, R; Kuhnz, W | 1 |
| Blode, H; Kuhnz, W; Mahler, M | 1 |
| Beier, S; Kuhnz, W | 1 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
| Schwingl, PJ; Shelton, J | 1 |
| Bloemenkamp, KW; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP | 1 |
| Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R | 1 |
| Duda, M; Edom, RW; Huang, M; Juzwin, S; Tegegne, G; Tischio, JP; Wong, FA | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Abrams, LS; Lasseter, KC; Natarajan, J; Skee, DM; Wong, FA | 1 |
| Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
| Creinin, MD; Eder, SE; Godwin, AJ; Lippman, JS; Olson, W | 1 |
| Taneepanichskul, S; Tantbirojn, P | 1 |
| Abrams, LS; Allen, JG; Creasy, GW; Hammond, GL; Natarajan, J; Siiteri, PK | 1 |
| Baerwald, AR; Olatunbosun, OA; Pierson, RA | 1 |
| Birtch, RL; Olatunbosun, OA; Pierson, RA | 1 |
| Jick, H; Jick, SS; Kaye, JA; Russmann, S | 1 |
| Jick, H; Jick, SS | 1 |
| Burrows, M; Peters, C | 1 |
| Bacquet, A; Balaguer, P; Paris, F; Rabeolina, F; Sultan, C | 1 |
| Tan, JK | 1 |
| Buono, MJ; Martin, JG | 1 |
| Cecchini, R; Gold, MA; Land, SR; Murray, PJ; Sucato, GS | 1 |
| Lidegaard, O; Løkkegaard, E; Nielsen, LH; Skovlund, CW | 1 |
| Curtis, KM; Dragoman, MV; Gaffield, ME; Tepper, NK | 1 |
| Del Savio, MC; Facchinetti, F; Grandi, G | 1 |
5 review(s) available for norgestimate and levonorgestrel
| Article | Year |
|---|---|
Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites.
Topics: Animals; Biotransformation; Contraceptives, Oral; Drug Combinations; Female; Humans; Levonorgestrel; Molecular Structure; Norgestrel; Oximes | 1990 |
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Female; Humans; Levonorgestrel; Norgestrel; Progestins; Risk Factors; Thromboembolism; Venous Thromboembolism; Young Adult | 2017 |
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism.
Topics: Animals; Contraceptive Agents, Hormonal; Female; Humans; Levonorgestrel; Norgestrel; Risk; Venous Thromboembolism | 2021 |
13 trial(s) available for norgestimate and levonorgestrel
| Article | Year |
|---|---|
A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
Topics: Adolescent; Adult; Androgens; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Lipids; Norgestrel | 1992 |
Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovulation; Progesterone; Sex Hormone-Binding Globulin | 1992 |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Contraceptives, Oral; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Levonorgestrel; Norethindrone; Norgestrel; Prothrombin; Thromboxane B2 | 1995 |
Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women.
Topics: Adolescent; Adult; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norgestrel | 1994 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Contraceptive Agents, Female; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Oximes; Time Factors | 2001 |
The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovarian Follicle; Patient Compliance; Progesterone | 2002 |
Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Thailand; Uterine Hemorrhage | 2002 |
Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Treatment Outcome; Ultrasonography | 2004 |
Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Female; Humans; Levonorgestrel; Menstrual Cycle; Norgestrel; Ovarian Follicle; Time Factors; Ultrasonography | 2006 |
Androgenicity of the progestin in oral contraceptives does not affect maximal leg strength.
Topics: Adult; Androgens; Contraceptives, Oral, Combined; Ethinyl Estradiol; Exercise; Female; Humans; Leg; Levonorgestrel; Muscle Strength; Norgestrel; Progesterone Congeners; Progestins; Sports | 2006 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
18 other study(ies) available for norgestimate and levonorgestrel
| Article | Year |
|---|---|
Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin.
Topics: Binding, Competitive; Desogestrel; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progestins; Sex Hormone-Binding Globulin; Testosterone | 1990 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
The affinity of norgestimate for uterine progestogen receptors and its direct action on the uterus.
Topics: Animals; Binding, Competitive; Chromatography, High Pressure Liquid; Endometrium; Female; Levonorgestrel; Norgestrel; Progesterone; Rabbits; Receptors, Progesterone; Uterus | 1985 |
Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor.
Topics: Animals; Drug Combinations; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Pregnancy; Pregnancy Maintenance; Progesterone; Rabbits; Rats; Rats, Wistar; Receptors, Progesterone | 1995 |
Comparative progestational and androgenic activity of norgestimate and levonorgestrel in the rat.
Topics: Androgens; Animals; Female; Kinetics; Levonorgestrel; Male; Norgestrel; Orchiectomy; Organ Size; Pregnancy; Pregnancy Maintenance; Progesterone Congeners; Prostate; Rats; Seminal Vesicles | 1994 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism | 1996 |
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States | 1997 |
Risk of oral contraceptives and recency of market introduction.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Time Factors | 1997 |
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis | 1997 |
Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Stability; Female; Humans; Levonorgestrel; Mass Spectrometry; Molecular Structure; Norgestrel; Oximes; Quality Control; Reproducibility of Results; Sensitivity and Specificity | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Odds Ratio; Risk Factors; Thromboembolism | 2006 |
Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
Topics: Administration, Cutaneous; Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Intracranial Thrombosis; Levonorgestrel; Norgestrel; Risk; Sinus Thrombosis, Intracranial | 2006 |
Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Animals; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Humans; Levonorgestrel; Norgestrel; Oximes; Protein Binding; Receptors, Androgen; Time Factors; Transfection | 2007 |
Adolescents' experiences using the contraceptive patch versus pills.
Topics: Adolescent; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Longitudinal Studies; Menstruation; Norgestrel; Patient Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires; Transdermal Patch; Young Adult | 2011 |
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Topics: Adolescent; Adult; Anticoagulants; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Denmark; Drug Implants; Epidemiologic Methods; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Transdermal Patch; Venous Thrombosis; Young Adult | 2012 |